Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations.
Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations.
复制标题
2型糖尿病的癌症风险：代谢联系和治疗方面的考虑。
DOI：
10.1155/2011/708183
复制
发表时间：
2011
影响因子：
2.2
通讯作者：
Kashyap SR
中科院分区：
文献类型：
--
作者：
Sun G;Kashyap SR
2 型糖尿病 (DM2) 的发病率不断上升，引发了全球公共卫生问题并影响发病率和死亡率。越来越多的研究证明 DM2 与恶性肿瘤之间存在共同关联，包括关键的临床、生化和代谢共性。本文将尝试探讨各种类型的癌症与糖尿病之间的关系、癌症发展的常见代谢途径以及各种抗糖尿病疗法对癌症风险的潜在影响。
Type 2 diabetes mellitus (DM2) is increasing in incidence, creating worldwide public health concerns and impacting morbidity and mortality rates. An increasing number of studies have demonstrated shared associations between DM2 and malignancy, including key clinical, biochemical, and metabolic commonalities. This paper will attempt to explore the relationship between the various types of cancer and diabetes, the common metabolic pathways underlying cancer development, and the potential impact of various antidiabetes therapies on cancer risk.